Aflac Incorporated (NYSE:AFL) Shares Acquired by abrdn plc

abrdn plc grew its position in Aflac Incorporated (NYSE:AFL) by 51.2% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 298,226 shares of the financial services provider’s stock after acquiring an additional 100,937 shares during the quarter. abrdn plc owned about 0.05% of Aflac worth $24,604,000 at the end of the most recent reporting period.

Other large investors have also modified their holdings of the company. Fortitude Family Office LLC acquired a new stake in shares of Aflac in the fourth quarter valued at approximately $25,000. Impact Partnership Wealth LLC lifted its holdings in shares of Aflac by 471.4% during the third quarter. Impact Partnership Wealth LLC now owns 400 shares of the financial services provider’s stock worth $31,000 after purchasing an additional 330 shares during the period. Bruce G. Allen Investments LLC acquired a new stake in shares of Aflac during the fourth quarter worth $32,000. Harvest Fund Management Co. Ltd acquired a new stake in shares of Aflac during the third quarter worth $33,000. Finally, Arlington Trust Co LLC acquired a new stake in shares of Aflac during the fourth quarter worth $35,000. 67.44% of the stock is owned by institutional investors and hedge funds.

Aflac Trading Up 0.3 %

Shares of AFL stock opened at $83.75 on Wednesday. Aflac Incorporated has a fifty-two week low of $64.10 and a fifty-two week high of $86.26. The stock has a market cap of $48.19 billion, a P/E ratio of 10.81, a P/E/G ratio of 2.28 and a beta of 0.91. The business has a fifty day simple moving average of $82.43 and a 200-day simple moving average of $81.68. The company has a quick ratio of 0.06, a current ratio of 0.06 and a debt-to-equity ratio of 0.33.

Aflac (NYSE:AFL) last announced its quarterly earnings results on Thursday, February 1st. The financial services provider reported $1.25 earnings per share for the quarter, missing analysts’ consensus estimates of $1.47 by ($0.22). Aflac had a net margin of 24.92% and a return on equity of 17.59%. The firm had revenue of $3.78 billion during the quarter, compared to analysts’ expectations of $4.44 billion. During the same quarter in the prior year, the business earned $1.29 EPS. On average, analysts forecast that Aflac Incorporated will post 6.41 earnings per share for the current fiscal year.

Insider Activity at Aflac

In related news, Director Masatoshi Koide sold 30,493 shares of the stock in a transaction on Friday, February 16th. The stock was sold at an average price of $79.91, for a total transaction of $2,436,695.63. Following the sale, the director now owns 86,090 shares of the company’s stock, valued at $6,879,451.90. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. In related news, Director Thomas J. Kenny sold 5,000 shares of the stock in a transaction on Wednesday, March 20th. The stock was sold at an average price of $84.62, for a total transaction of $423,100.00. Following the sale, the director now owns 17,920 shares of the company’s stock, valued at $1,516,390.40. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, Director Masatoshi Koide sold 30,493 shares of the firm’s stock in a transaction dated Friday, February 16th. The stock was sold at an average price of $79.91, for a total value of $2,436,695.63. Following the completion of the sale, the director now directly owns 86,090 shares in the company, valued at $6,879,451.90. The disclosure for this sale can be found here. Insiders have sold a total of 46,493 shares of company stock valued at $3,765,706 over the last quarter. Insiders own 0.80% of the company’s stock.

Wall Street Analyst Weigh In

Several brokerages recently weighed in on AFL. Wells Fargo & Company decreased their price target on Aflac from $83.00 to $81.00 and set an “equal weight” rating for the company in a report on Thursday, April 11th. The Goldman Sachs Group increased their price target on Aflac from $61.00 to $75.00 and gave the stock a “sell” rating in a report on Tuesday, January 9th. Piper Sandler increased their price target on Aflac from $90.00 to $95.00 and gave the stock an “overweight” rating in a report on Friday, April 5th. StockNews.com downgraded Aflac from a “hold” rating to a “sell” rating in a report on Wednesday, April 10th. Finally, Morgan Stanley increased their price objective on Aflac from $80.00 to $84.00 and gave the stock an “equal weight” rating in a research report on Monday, April 15th. Three investment analysts have rated the stock with a sell rating, eight have given a hold rating and three have assigned a buy rating to the company’s stock. According to MarketBeat, the company presently has an average rating of “Hold” and a consensus target price of $82.15.

Aflac Company Profile

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.